Practice Test Geeks(ASC) Advanced Stroke Coordinator Certification Practice Test
← All ASC Flashcard Decks

Stroke Prevention & Risk Management Flashcards

7 cards from real ASC practice questions. Tap to flip, then mark Knew It or Still Learning — missed cards come back until you master them.

Read the first 7 Stroke Prevention & Risk Management flashcards as text

  1. A patient with lacunar infarct and well-controlled hypertension is found to have no AF on 30-day cardiac monitoring. Which antithrombotic regimen is preferred for secondary prevention?

    Answer: Single antiplatelet agent (aspirin or clopidogrel)

    Single antiplatelet therapy is preferred for lacunar stroke secondary prevention, as anticoagulation and long-term DAPT have not shown superior benefit and increase bleeding risk.

  2. Obstructive sleep apnea (OSA) is an independent risk factor for stroke. Which intervention is recommended to reduce stroke risk in patients with moderate-to-severe OSA?

    Answer: Continuous positive airway pressure (CPAP) therapy

    CPAP therapy is the recommended treatment for moderate-to-severe OSA and is associated with reduced cardiovascular and stroke risk.

  3. Which scoring tool is specifically designed to assess early stroke risk after a TIA to guide urgency of evaluation?

    Answer: ABCD2 score

    The ABCD2 score (Age, Blood pressure, Clinical features, Duration, Diabetes) stratifies early stroke risk following TIA to prioritize rapid evaluation.

  4. A 55-year-old patient with no prior cardiovascular disease is found to have a 10-year cardiovascular risk of 9%. Aspirin for primary prevention is:

    Answer: Not recommended due to net harm from bleeding risk

    Current guidelines recommend against routine aspirin for primary prevention in adults without established cardiovascular disease due to bleeding risk exceeding modest cardiovascular benefit.

  5. In patients with symptomatic intracranial atherosclerotic disease (ICAD) causing 70–99% stenosis, which combination is recommended for secondary prevention?

    Answer: Aspirin plus clopidogrel for 90 days, then single antiplatelet

    The SAMMPRIS trial supports aspirin plus clopidogrel for 90 days followed by aspirin monotherapy combined with aggressive risk factor management for high-grade ICAD.

  6. A stroke coordinator is counseling a patient about modifiable stroke risk factors. Which factor contributes the MOST to global stroke burden?

    Answer: Hypertension

    Hypertension is the single largest modifiable risk factor for stroke globally, accounting for approximately 54% of stroke mortality.

  7. Which antihypertensive drug class has the strongest evidence specifically for reducing recurrent stroke risk when used in post-stroke patients?

    Answer: ACE inhibitors with thiazide diuretics

    The PROGRESS trial demonstrated that the combination of perindopril (ACE inhibitor) plus indapamide (thiazide-like diuretic) significantly reduced recurrent stroke risk.